This volume is designed to feature the pharmacology of new psychoactive substances, legislative aspects, information exchange including epidemiology, and clinical, forensic, and analytical toxicology in order to facilitate the understanding of this complex and rapidly developing phenomenon.
Gives an update of the multi-layered facets of the “designer drugs” phenomenon that exploded into public’s consciousness in the 2010s Offers diverse perspectives in areas of neuropharmacology, analytical toxicology, epidemiology of adverse events and information-exchange Provides accurate information about psychoactive recreational substances that transcended ‘traditional’ drugs of abuse
Hans H. Maurer
New psychoactive substances Designer drugs Neuropsychopharmacology Public health Analytical toxicology